| In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195 E Rissanen, J Tuisku, J Rokka, T Paavilainen, R Parkkola, JO Rinne, ... Journal of Nuclear Medicine 55 (6), 939-944, 2014 | 174 | 2014 |
| Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity H Högel, E Rissanen, C Barro, M Matilainen, M Nylund, J Kuhle, L Airas Multiple Sclerosis Journal 26 (2), 210-219, 2020 | 129 | 2020 |
| Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis M Sucksdorff, M Matilainen, J Tuisku, E Polvinen, A Vuorimaa, J Rokka, ... Brain 143 (11), 3318-3330, 2020 | 101 | 2020 |
| Adenosine A2A receptors in secondary progressive multiple sclerosis: a [11C] TMSX brain PET study E Rissanen, JR Virta, T Paavilainen, J Tuisku, S Helin, P Luoto, ... Journal of Cerebral Blood Flow & Metabolism 33 (9), 1394-1401, 2013 | 98 | 2013 |
| Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study J Tuisku, P Plavén-Sigray, EC Gaiser, L Airas, H Al-Abdulrasul, A Brück, ... European journal of nuclear medicine and molecular imaging 46, 2329-2338, 2019 | 85 | 2019 |
| Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis M Sucksdorff, E Rissanen, J Tuisku, S Nuutinen, T Paavilainen, J Rokka, ... Journal of Nuclear Medicine 58 (10), 1646-1651, 2017 | 82 | 2017 |
| Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography L Airas, M Nylund, E Rissanen Frontiers in Neurology 9, 341831, 2018 | 69 | 2018 |
| Microglial activation, white matter tract damage, and disability in MS E Rissanen, J Tuisku, T Vahlberg, M Sucksdorff, T Paavilainen, ... Neurology: Neuroimmunology & Neuroinflammation 5 (3), e443, 2018 | 66 | 2018 |
| Imaging neuroinflammation in multiple sclerosis using TSPO-PET L Airas, E Rissanen, JO Rinne Clinical and translational imaging 3, 461-473, 2015 | 55 | 2015 |
| Natalizumab treatment reduces microglial activation in the white matter of the MS brain M Sucksdorff, J Tuisku, M Matilainen, A Vuorimaa, S Smith, J Keitilä, ... Neurology: Neuroimmunology & Neuroinflammation 6 (4), e574, 2019 | 47 | 2019 |
| Automated Reference Region Extraction and Population-Based Input Function for Brain [11C]TMSX PET Image Analyses E Rissanen, J Tuisku, P Luoto, E Arponen, J Johansson, V Oikonen, ... Journal of Cerebral Blood Flow & Metabolism 35 (1), 157-165, 2015 | 47 | 2015 |
| Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study N Kemppainen, J Johansson, J Teuho, R Parkkola, J Joutsa, T Ngandu, ... Neurology 90 (3), e206-e213, 2018 | 45 | 2018 |
| Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging S Bezukladova, J Tuisku, M Matilainen, A Vuorimaa, M Nylund, S Smith, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e691, 2020 | 33 | 2020 |
| In vivo PET imaging of adenosine 2A receptors in neuroinflammatory and neurodegenerative disease A Vuorimaa, E Rissanen, L Airas Contrast Media & Molecular Imaging 2017, 2017 | 32 | 2017 |
| Imaging of microglial activation in MS using PET: Research use and potential future clinical application L Airas, E Rissanen, J Rinne Multiple Sclerosis Journal 23 (4), 496-504, 2017 | 30 | 2017 |
| High serum neurofilament associates with diffuse white matter damage in MS M Saraste, S Bezukladova, M Matilainen, J Tuisku, E Rissanen, ... Neurology: Neuroimmunology & Neuroinflammation 8 (1), e926, 2020 | 29 | 2020 |
| Circulating neurofilament is linked with morbid obesity, renal function, and brain density E Rebelos, E Rissanen, M Bucci, O Jääskeläinen, MJ Honka, ... Scientific reports 12 (1), 7841, 2022 | 28 | 2022 |
| Positron emission tomography imaging in evaluation of MS pathology in vivo H Högel, E Rissanen, A Vuorimaa, L Airas Multiple Sclerosis Journal 24 (11), 1399-1412, 2018 | 27 | 2018 |
| Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET) E Rissanen, T Paavilainen, J Virta, RJ Marttila, JO Rinne, L Airas Neurotoxicology 31 (4), 403-407, 2010 | 27 | 2010 |
| Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland L Airas, M Nylund, I Mannonen, M Matilainen, M Sucksdorff, E Rissanen Multiple sclerosis and related disorders 40, 101980, 2020 | 24 | 2020 |
